Abbott Laboratories

-12.77%

More reviews (1)

Live  

Abbott Laboratories is an American multinational healthcare company that specializes in the development, manufacturing, and sale of pharmaceuticals, medical devices, and diagnostic products. It was founded in 1888 by Chicago physician Wallace Calvin Abbott and has its headquarters in Abbott Park, Illinois.
Today, Abbott Laboratories is one of the largest and most diversified healthcare companies in the world, with a presence in more than 160 countries. It is divided into four main business segments: Established Pharmaceuticals, Nutritionals, Medical Devices, and Diagnostics.
The company's pharmaceutical division focuses on developing and manufacturing prescription drugs for various therapeutic areas such as cardiovascular, neuroscience, and immunology. Its nutritional division is known for producing a wide range of nutritional products, including infant formula, adult nutrition, and diabetes care products.
Abbott Laboratories also has a significant presence in the medical device industry, producing products such as diabetes care devices, cardiovascular devices, and vision care products. Its diagnostics division offers a variety of laboratory instruments, reagents, and assays for the detection of diseases.
In addition to its core healthcare products, Abbott Laboratories also has a strong commitment to improving global health, particularly in developing countries. The company invests millions of dollars in programs and partnerships aimed at combating health issues like HIV/AIDS, malnutrition, and maternal and child health.
Overall, Abbott Laboratories has a long history of innovation and a strong commitment to improving people's lives through its products and initiatives. It continues to be a leader in the healthcare industry, constantly evolving and adapting to the changing needs of patients and healthcare providers.

Abbott Laboratories is a big company that helps people stay healthy. They make lots of different things like medicines, special food for people who need extra help, and tools that doctors use to check how healthy we are. For example, they make tests to find out if someone is sick and even machines that can help keep our hearts working well.
Abbott makes money by selling these products to hospitals, doctors, and pharmacies. When someone buys their medicine or medical equipment, Abbott gets paid for it. They also create special products for babies and other people who need help with their diets. Because they offer many different items, they can help lots of people and make money in many ways.
Abbott has been successful for a long time because they always try to invent new and better products. They also make sure their products are really good and safe, which helps doctors and patients trust them. In the future, they will likely continue to be successful because they keep researching and developing new technology to help people, especially as our world has new health challenges. People will always need help staying healthy, and because Abbott is good at providing that help, they will likely keep doing well for years to come.

MS4gTG9uZy BIaXN0b3J5 OiBBYmJvdH QgTGFib3Jh dG9yaWVzIG hhcyBiZWVu IGluIGV4aX N0ZW5jZSBm b3Igb3Zlci AxMzAgeWVh cnMsIG1ha2 luZyBpdCBv bmUgb2YgdG hlIG9sZGVz dCBhbmQgbW 9zdCBlc3Rh Ymxpc2hlZC Bjb21wYW5p ZXMgaW4gdG hlIGhlYWx0 aGNhcmUgaW 5kdXN0cnku PGJyPjIuIE 11bHRpLVNw ZWNpYWx0eS BDb21wYW55 OiBBYmJvdH QgTGFib3Jh dG9yaWVzIG 9wZXJhdGVz IGluIGEgZG l2ZXJzZSBy YW5nZSBvZi BzZWN0b3Jz IGluY2x1ZG luZyBwaGFy bWFjZXV0aW NhbHMsIG1l ZGljYWwgZG V2aWNlcywg ZGlhZ25vc3 RpY3MsIGFu ZCBudXRyaX Rpb24sIGdp dmluZyB0aG UgY29tcGFu eSBhIHdpZG UgcmVhY2gg aW4gdGhlIG hlYWx0aGNh cmUgbWFya2 V0Ljxicj4z LiBHbG9iYW wgUHJlc2Vu Y2U6IFdpdG ggb3BlcmF0 aW9ucyBpbi Btb3JlIHRo YW4gMTYwIG NvdW50cmll cywgQWJib3 R0IExhYm9y YXRvcmllcy BoYXMgYSBz dHJvbmcgZ2 xvYmFsIHBy ZXNlbmNlLC BhbGxvd2lu ZyBpdCB0by BzZXJ2ZSBh IGRpdmVyc2 UgcmFuZ2Ug b2YgY3VzdG 9tZXJzIHdv cmxkd2lkZS 48YnI+NC4g U3Ryb25nIE ZvY3VzIG9u IFJlc2Vhcm NoIGFuZCBE ZXZlbG9wbW VudDogVGhl IGNvbXBhbn kgaGFzIGEg ZGVkaWNhdG VkIHJlc2Vh cmNoIGFuZC BkZXZlbG9w bWVudCB0ZW FtIHRoYXQg Zm9jdXNlcy BvbiBkZXZl bG9waW5nIG lubm92YXRp dmUgcHJvZH VjdHMgYW5k IHRlY2hub2 xvZ2llcyB0 byBhZGRyZX NzIHVubWV0 IG1lZGljYW wgbmVlZHMg YW5kIGltcH JvdmUgcGF0 aWVudCBvdX Rjb21lcy48 YnI+NS4gU3 Ryb25nIFBv cnRmb2xpby BvZiBQcm9k dWN0czogQW Jib3R0IExh Ym9yYXRvcm llcyBoYXMg YSBzdHJvbm cgcG9ydGZv bGlvIG9mIH Byb2R1Y3Rz LCBpbmNsdW RpbmcgcG9w dWxhciBicm FuZHMgc3Vj aCBhcyBTaW 1pbGFjLCBF bnN1cmUsIG FuZCBGcmVl c3R5bGUgTG licmUsIHdo aWNoIGFyZS B0cnVzdGVk IGJ5IGhlYW x0aGNhcmUg cHJvZmVzc2 lvbmFscyBh bmQgcGF0aW VudHMgd29y bGR3aWRlLj xicj42LiBD b21taXRtZW 50IHRvIFN1 c3RhaW5hYm lsaXR5OiBU aGUgY29tcG FueSBoYXMg YSBzdHJvbm cgY29tbWl0 bWVudCB0by BzdXN0YWlu YWJpbGl0eS BhbmQgaGFz IGltcGxlbW VudGVkIHZh cmlvdXMgaW 5pdGlhdGl2 ZXMgdG8gcm VkdWNlIGl0 cyBlbnZpcm 9ubWVudGFs IGltcGFjdC wgaW1wcm92 ZSBhY2Nlc3 MgdG8gaGVh bHRoY2FyZS wgYW5kIHN1 cHBvcnQgbG 9jYWwgY29t bXVuaXRpZX MuPGJyPjcu IEhpZ2gtUX VhbGl0eSBT dGFuZGFyZH M6IEFiYm90 dCBMYWJvcm F0b3JpZXMg aGFzIGEgcm VwdXRhdGlv biBmb3IgbW FpbnRhaW5p bmcgaGlnaC 1xdWFsaXR5 IHN0YW5kYX JkcyBpbiBp dHMgcHJvZH VjdHMgYW5k IHByb2Nlc3 NlcywgZW5z dXJpbmcgc2 FmZXR5IGFu ZCBlZmZpY2 FjeSBmb3Ig cGF0aWVudH MuPGJyPjgu IEZvY3VzIG 9uIEN1c3Rv bWVyIE5lZW RzOiBUaGUg Y29tcGFueS dzIGN1c3Rv bWVyLWNlbn RyaWMgYXBw cm9hY2ggaX MgcmVmbGVj dGVkIGluIG l0cyBjb21t aXRtZW50IH RvIG1lZXRp bmcgdGhlIG 5lZWRzIG9m IHBhdGllbn RzLCBoZWFs dGhjYXJlIH Byb2Zlc3Np b25hbHMsIG FuZCBvdGhl ciBzdGFrZW hvbGRlcnMu PGJyPjkuIF N0cm9uZyBG aW5hbmNpYW wgUGVyZm9y bWFuY2U6IE FiYm90dCBM YWJvcmF0b3 JpZXMgaGFz IGNvbnNpc3 RlbnRseSBk ZWxpdmVyZW Qgc3Ryb25n IGZpbmFuY2 lhbCBwZXJm b3JtYW5jZS wgbWFraW5n IGl0IGEgcm VsaWFibGUg YW5kIHN0YW JsZSBjb21w YW55IGZvci BpbnZlc3Rv cnMuPGJyPj EwLiBTdHJv bmcgQ29ycG 9yYXRlIEN1 bHR1cmU6IF RoZSBjb21w YW55IGhhcy BhIHN0cm9u ZyBjb3Jwb3 JhdGUgY3Vs dHVyZSB0aG F0IHZhbHVl cyBkaXZlcn NpdHksIGlu Y2x1c2lvbi wgYW5kIGVt cGxveWVlIH dlbGwtYmVp bmcsIG1ha2 luZyBpdCBh IGRlc2lyYW JsZSBwbGFj ZSB0byB3b3 JrIGZvciBl bXBsb3llZX Mu

VGhlIGNvcm UgYnVzaW5l c3MgbW9kZW wgb2YgQWJi b3R0IExhYm 9yYXRvcmll cyBpcyB0by BkZXZlbG9w LCBtYW51Zm FjdHVyZSwg YW5kIG1hcm tldCBhIGRp dmVyc2Ugcm FuZ2Ugb2Yg aGVhbHRoY2 FyZSBwcm9k dWN0cyBhbm Qgc2Vydmlj ZXMsIGluY2 x1ZGluZyBw aGFybWFjZX V0aWNhbHMs IG1lZGljYW wgZGV2aWNl cywgZGlhZ2 5vc3RpY3Ms IGFuZCBudX RyaXRpb24g cHJvZHVjdH MuIFRoZSBj b21wYW55IG 9wZXJhdGVz IGluIHNldm VyYWwgc2Vn bWVudHMsIG luY2x1ZGlu ZyBFc3RhYm xpc2hlZCBQ aGFybWFjZX V0aWNhbHMs IE1lZGljYW wgRGV2aWNl cywgTnV0cm l0aW9uLCBh bmQgRGlhZ2 5vc3RpY3Mu IDxicj5BYm JvdHQgTGFi b3JhdG9yaW VzJyBidXNp bmVzcyBzdH JhdGVneSBm b2N1c2VzIG 9uIGlubm92 YXRpb24gYW 5kIGFjcXVp c2l0aW9uIH RvIGV4cGFu ZCBpdHMgcH JvZHVjdCBw b3J0Zm9saW 8gYW5kIGVu dGVyIG5ldy BtYXJrZXRz LiBUaGUgY2 9tcGFueSBp bnZlc3RzIG hlYXZpbHkg aW4gcmVzZW FyY2ggYW5k IGRldmVsb3 BtZW50IHRv IGRldmVsb3 AgbmV3IGFu ZCBpbm5vdm F0aXZlIGhl YWx0aGNhcm Ugc29sdXRp b25zLCB3aG ljaCBhcmUg dGhlbiBtYX JrZXRlZCBn bG9iYWxseS 4gQWRkaXRp b25hbGx5LC BBYmJvdHQg TGFib3JhdG 9yaWVzIGFj cXVpcmVzIG 90aGVyIGNv bXBhbmllcy B0byBkaXZl cnNpZnkgaX RzIHByb2R1 Y3Qgb2ZmZX JpbmdzIGFu ZCBleHBhbm QgaXRzIGds b2JhbCBwcm VzZW5jZS4g PGJyPlRoZS Bjb21wYW55 IGFsc28gaG FzIGEgc3Ry b25nIGZvY3 VzIG9uIGZp bmFuY2lhbC BkaXNjaXBs aW5lLCBjb3 N0IGNvbnRy b2wsIGFuZC BvcGVyYXRp b25hbCBlZm ZpY2llbmN5 IHRvIGRyaX ZlIHByb2Zp dGFiaWxpdH kgYW5kIGxv bmctdGVybS Bncm93dGgu IEl0cyBleH RlbnNpdmUg ZGlzdHJpYn V0aW9uIG5l dHdvcmsgYW 5kIHBhcnRu ZXJzaGlwcy B3aXRoIGhl YWx0aGNhcm UgcHJvdmlk ZXJzIGFuZC Bnb3Zlcm5t ZW50cyBlbm FibGUgaXQg dG8gcmVhY2 ggYSB3aWRl IGN1c3RvbW VyIGJhc2Ug YW5kIGVuc3 VyZSB0aGUg YXZhaWxhYm lsaXR5IG9m IGl0cyBwcm 9kdWN0cyBh bmQgc2Vydm ljZXMuIDxi cj5PdmVyYW xsLCBBYmJv dHQgTGFib3 JhdG9yaWVz JyBidXNpbm VzcyBtb2Rl bCBjZW50ZX JzIG9uIHBy b3ZpZGluZy BxdWFsaXR5 IGFuZCBpbm 5vdmF0aXZl IGhlYWx0aG NhcmUgc29s dXRpb25zIH doaWxlIGV4 cGFuZGluZy BpdHMgZ2xv YmFsIHJlYW NoIHRocm91 Z2ggYSBjb2 1iaW5hdGlv biBvZiBvcm dhbmljIGdy b3d0aCBhbm Qgc3RyYXRl Z2ljIGFjcX Vpc2l0aW9u cy4=

AI does pose potential challenges to Abbott Laboratories in several ways.
Firstly, substitution could occur if AI-driven innovations lead to alternative health solutions that compete with Abbott’s products. For instance, advancements in telemedicine and digital health platforms could offer consumers alternative diagnostics or health management tools that reduce reliance on traditional medical devices and tests that Abbott provides.
Secondly, disintermediation may happen as AI technologies streamline processes, connecting healthcare providers directly with patients. This shift could lessen the role of intermediaries and traditional healthcare channels that Abbott relies on for distribution and supply of its products.
Lastly, margin pressure could arise due to increased competition from tech companies entering the healthcare space. As AI lowers the costs of developing and delivering certain healthcare applications, it could compress the margins on Abbott’s products if they face pressure to reduce prices in response.
In summary, while AI can offer opportunities for innovation and efficiency, it also presents material threats to Abbott Laboratories through substitution of their products, potential disintermediation in healthcare delivery, and increased margin pressure resulting from heightened competition.

The sensitivity of Abbott Laboratories’ earnings, cash flow, and valuation to changes in interest rates can be understood through several key factors:
1. Debt Levels: If Abbott has significant outstanding debt, rising interest rates can lead to increased interest expenses. This can adversely affect net earnings and cash flow, especially if the company is unable to pass on these costs to consumers through higher prices.
2. Cost of Capital: Interest rates impact the overall cost of capital. Higher rates can lead to a higher discount rate in discounted cash flow (DCF) valuation models, which can decrease the present value of future cash flows. As a result, an increase in interest rates may lower Abbott’s valuation.
3. Consumer Spending: In a high-interest-rate environment, consumers may reduce spending on health-related products and services, which could directly impact Abbott’s sales and revenue growth. This effect can vary depending on the specific segment of Abbott’s business, such as medical devices, diagnostics, or nutrition.
4. Investment in R&D: Changes in interest rates can affect Abbott’s decisions regarding capital expenditures and investment in research and development. Higher borrowing costs might lead to more stringent capital allocation, potentially impacting long-term growth and innovation.
5. Market Sentiment: Interest rates influence overall market sentiment and investor behavior. Rising rates may lead to a shift in investment strategies, with investors potentially favoring less volatile investments (like bonds) over equities, including those of Abbott.
6. Foreign Exposure: Abbott operates globally, and changes in interest rates can also affect foreign exchange rates. If interest rates rise in the U.S., it could strengthen the dollar, making Abbott’s international sales less competitive.
Overall, Abbott Laboratories’ earnings, cash flow, and valuation are sensitive to changes in interest rates due to their impact on borrowing costs, consumer behavior, market conditions, and investment strategy.

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvMW VnWkFwdHRC bjhOcERNTE xQaHMud2Vi cCIgYWx0PS JBYmJvdHQg TGFib3JhdG 9yaWVzIiB0 aXRsZT0iQW Jib3R0IExh Ym9yYXRvcm llcyIgIGNs YXNzPSJpbW ctZmx1aWQi IGhlaWdodD 05MCB3aWR0 aD05MCBsb2 FkaW5nPSds YXp5JyBzdH lsZT0nYm9y ZGVyLXJhZG l1czogNnB4 Oyc+CgogIC AgICAgICAg ICAgICAgIC AgIDxkaXYg c3R5bGU9J2 ZsZXg6IDE7 IHRleHQtYW xpZ246IGNl bnRlcjsgbW FyZ2luLWxl ZnQ6IDVweD snPgogICAg ICAgICAgIC AgICAgICAg ICAgICA8cC BzdHlsZT0n Zm9udC1zaX plOiAyNnB4 OyBjb2xvcj ogIzMzMzsg bWFyZ2luLW JvdHRvbTog MTVweDsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAg8J +TiCBXYW50 IHRvIHJlYW QgbW9yZSBh Ym91dCBBYm JvdHQgTGFi b3JhdG9yaW VzPwogICAg ICAgICAgIC AgICAgICAg ICAgICA8L3 A+CgogICAg ICAgICAgIC AgICAgICAg ICAgICA8YS BocmVmPSdp bmRleC5waH A/cGFnZT1z aWdudXAnIH N0eWxlPScK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGJh Y2tncm91bm QtY29sb3I6 ICMwMDdCRk Y7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bjb2xvcjog I2ZmZjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHBhZG Rpbmc6IDEw cHggMjBweD sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG JvcmRlci1y YWRpdXM6ID VweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIHRleHQt ZGVjb3JhdG lvbjogbm9u ZTsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGZvbnQtd2 VpZ2h0OiBi b2xkOwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbWFyZ2 luLXJpZ2h0 OiAxMHB4Ow ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgdH JhbnNpdGlv bjogYmFja2 dyb3VuZC1j b2xvciAwLj NzIGVhc2U7 JwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg b25tb3VzZW 92ZXI9J3Ro aXMuc3R5bG UuYmFja2dy b3VuZENvbG 9yPSIjMDA1 NmIzIicKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIG9ubW 91c2VvdXQ9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA3QkZGIi c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BTaWduIHVw IGZvciBmcm VlCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxzcG FuIHN0eWxl PSdtYXJnaW 46IDAgOHB4 OyBjb2xvcj ogIzU1NTsn Pm9yPC9zcG FuPgoKICAg ICAgICAgIC AgICAgICAg ICAgICAgPG EgaHJlZj0n aW5kZXgucG hwP3BhZ2U9 bG9naW4nIH N0eWxlPScK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGNv bG9yOiAjMD A3QkZGOwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgdGV4 dC1kZWNvcm F0aW9uOiB1 bmRlcmxpbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogNT AwOyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBsb2cg aW4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9h PgoKCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxw IHN0eWxlPS dtYXJnaW4t dG9wOiAxNX B4OyBmb250 LXNpemU6ID EzcHg7IGZv bnQtd2VpZ2 h0OiBib2xk OyBjb2xvcj ogI2QzMmYy ZjsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAg8J+OgS BGcmVlIGRv d25sb2FkIS A8aT4iVGhl IENoZWNrbG lzdCBWYWx1 ZSBJbnZlc3 RvciDigJQg QSBTbWFydG VyIFdheSB0 byBQaWNrIF N0b2NrcyI8 L2k+CiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwv cD4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwh LS0KICAgIC AgICAgICAg ICAgICAgIC AgICAgPGRp diBzdHlsZT 0nbWFyZ2lu LXRvcDogMT JweDsgZm9u dC1zaXplOi AxM3B4OyBj b2xvcjogIz Q0NDsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgU2ln biB1cCBub3 cgYW5kIGdl dCBvdXIgZn JlZSBlQm9v ayAKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IDxiPlRoZS BDaGVja2xp c3QgVmFsdW UgSW52ZXN0 b3Ig4oCUIE EgU21hcnRl ciBXYXkgdG 8gUGljayBT dG9ja3M8L2 I+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC AgICAgICAg ICAgICAtLT 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPCEtLQ ogICAgICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdt YXJnaW4tdG 9wOiAxNnB4 OyBmb250LX NpemU6IDE0 cHg7IGNvbG 9yOiAjNDQ0 OyBmb250LW ZhbWlseTog LWFwcGxlLX N5c3RlbSwg QmxpbmtNYW NTeXN0ZW1G b250LCBTZW dvZSBVSSwg Um9ib3RvLC BIZWx2ZXRp Y2EgTmV1ZS wgc2Fucy1z ZXJpZjsgbG luZS1oZWln aHQ6IDEuNj snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgSGF2ZSB5 b3UgaGVhcm QgYWJvdXQg b3VyIHNob3 J0IDxzdHJv bmcgc3R5bG U9J2ZvbnQt d2VpZ2h0Oi A2MDA7Jz5E YWlseSBWaW RlbyBOZXdz bGV0dGVyPC 9zdHJvbmc+ PwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg PGEgaHJlZj 0naHR0cHM6 Ly93d3cuaW 5zaWdodGZ1 bHZhbHVlLm NvbS9uZXdz bGV0dGVyLn BocCcgdGFy Z2V0PSdfYm xhbmsnIHN0 eWxlPSdjb2 xvcjogIzAw N0JGRjsgdG V4dC1kZWNv cmF0aW9uOi Bub25lOyBm b250LXdlaW dodDogNTAw OyBtYXJnaW 4tbGVmdDog NnB4Oyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgRmluZCBv dXQgbW9yZQ ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9hPgogICAg ICAgICAgIC AgICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgICAgICAg ICAgICAgLS 0+CiAgICAg ICAgICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg IAogICAgIC AgIAogICAg ICAgIDxzcG FuIGNsYXNz PSdibHVycm VkLXRleHQn PgogICAgIC AgICAgICBN UzRnUVdKaW IzIFIwSUV4 aFltOXkgWV hSdmNtbGxj eSBCM1lYTW dabTkxIGJt UmxaQ0JwYm kgQXhPRGc0 SUdKNSBJRV J5TGlCWFlX IHhzWVdObE lFTXUgSUVG aVltOTBkQy B3Z2QyaHZJ SGRoIGN5Qm hJRU5vYVcg TmhaMjhnY0 doNSBjMmxq YVdGdUlHIE Z1WkNCd2FH RnkgYldGam FYTjBMaSBC SmJtbDBhV0 ZzIGJIa3NJ SFJvWlMgQm piMjF3WVc1 NSBJSGRoY3 lCbWIyIE4x YzJWa0lHOX UgSUcxaGJu Vm1ZVyBOMG RYSnBibWNn IFpISjFaM0 1nWVcgNWtJ SEJ5YjJSMS BZMmx1WnlC aWIzIFJoYm 1sallXd2cg WlhoMGNtRm pkSCBNc0lH SjFkQ0JwIG RDQnNZWFJs Y2kgQmxlSE JoYm1SbCBa Q0JwYm5Sdk lHIEpzYjI5 a0lHZHMgZF dOdmMyVWdi VyA5dWFYUn ZjbWx1IFp5 d2diblYwY2 0gbDBhVzl1 SUhCeSBiMl IxWTNSekxD IEJ0WldScF kyRnMgSUdS bGRtbGpaWC BNc0lHRnVa Q0JrIGFXRm 5ibTl6ZEcg bGpjeTQ4WW 5JKyBNaTRn VkdobElHIE 52YlhCaGJu bmkgZ0psek lHWnBjbiBO MElHMWhhbT l5IElHSnla V0ZyZEcgaH liM1ZuYUNC aiBZVzFsSU dsdUlEIEU0 T1RNc0lIZG 8gWlc0Z2FY UWdaRyBWMl pXeHZjR1Zr IElHRWdiV1 ZrYVcgTnBi bVVnWTJGcy BiR1ZrSUhS b1pTIEJCWW 1KdmRIUWcg UVd4cllXeH ZhVyBSaGJD QkRiMjF3IF lXNTU0b0Na Y3kgQk5aV1 JwWTJsdSBZ V3dnUkdsbl pYIE4wYVha bElFVnMgYV hocGNpNGdW RyBocGN5Qn RaV1JwIFky bHVaU0JpWl cgTmhiV1Vn ZDJsayBaV3 g1SUhCdmNI IFZzWVhJZ1 ptOXkgSUhK bGJHbGxkbS BsdVp5QndZ V2x1IElHRn VaQ0JwYlgg QnliM1pwYm 1jZyBaR2xu WlhOMGFXID l1TENCaGJt UWcgYVhRZ2 FHVnNjRyBW a0lIQjFkQ0 JCIFltSnZk SFFnVEcgRm liM0poZEc5 eSBhV1Z6SU c5dUlIIFJv WlNCdFlYQX UgUEdKeVBq TXVJRSBsdU lERTVNRE1z IElFRmlZbT kwZEMgQk1Z V0p2Y21GMC BiM0pwWlhN Z1ltIFZqWV cxbElHOXUg WlNCdlppQj BhRyBVZ1pt bHljM1FnIF kyOXRjR0Z1 YVcgVnpJSF J2SUhCeSBi MlIxWTJVZ1 lTIEJ6ZEdG dVpHRnkgWk dsNlpXUWda bSA5eWJTQn ZaaUJrIGFX ZHBkR0ZzYV ggTXNJR0Vn YUdWaCBjbl FnYldWa2FX IE5oZEdsdm JpNGcgVkdo cGN5Qm9aVy B4d1pXUWdj bVYyIGIyeD FkR2x2Ym0g bDZaU0IwYU dVZyBkSEps WVhSdFpXID UwSUc5bUlH aGwgWVhKME lHUnBjMiBW aGMyVXVQR0 p5IFBqUXVJ RVIxY20gbH VaeUJYYjNK cyBaQ0JYWV hJZ1NVIGtz SUVGaVltOT AgZENCTVlX SnZjbSBGMG IzSnBaWE1n IGNISnZaSF ZqWlcgUWdZ VzRnWlhody BaWEpwYldW dWRHIEZzSU dSeWRXY3Mg SUhCbGJtbG phVyB4c2FX NHNJR2x1IE lHeGhjbWRs SUggRjFZVz UwYVhScCBa WE11SUZSb2 FYIE1nZDJG eklIVnogWl dRZ2RHOGdk SCBKbFlYUW dkMjkxIGJt UmxaQ0J6Yj IgeGthV1Z5 Y3lCdiBiaU IwYUdVZ1pu IEp2Ym5RZ2 JHbHUgWlhN c0lHaGxiSC BCcGJtY2dk RzhnIGMyRj JaU0J0WVcg NTVJR3hwZG 1WeiBManhp Y2o0MUxpIE JCWW1KdmRI UWcgVEdGaW IzSmhkRyA5 eWFXVnpJR2 hoIGN5QmhJ R3h2Ym0gY2 dhR2x6ZEc5 eSBlU0J2Wm lCa1pYIFps Ykc5d2FXNW 4gSUdsdWJt OTJZWCBScG RtVWdiV1Zr IGFXTmhiQ0 JrWlggWnBZ MlZ6TGlCSi BiaUF4T1RV MExDIEIwYU dVZ1kyOXQg Y0dGdWVTQn BibiBSeWIy UjFZMlZrIE lIUm9aU0Jt YVggSnpkQ0 J0WVhOeiBM WEJ5YjJSMV kyIFZrSUdK c2IyOWsgSU dkc2RXTnZj MiBVZ2JXVj BaWElzIElI ZG9hV05vSU ggSmxkbTlz ZFhScCBiMj VwZW1Wa0lH IFJwWVdKbG RHVnogSUcx aGJtRm5aVy AxbGJuUXVQ R0p5IFBqWX VJRWx1SUQg SXdNVEVzSU VGaSBZbTkw ZENCTVlXIE p2Y21GMGIz SnAgWlhNZ2 MzQnNhWCBR Z2FXNTBieU IwIGQyOGdj MlZ3WVggSm hkR1VnWTI5 dCBjR0Z1YV dWek9pIEJC WW1KdmRIUX MgSUhkb2FX Tm9JRyBadl kzVnpaWE1n IGIyNGdiV1 ZrYVcgTmhi Q0JrWlhacC BZMlZ6TENC a2FXIEZuYm 05emRHbGog Y3l3Z1lXNW tJRyA1MWRI SnBkR2x2IG JpQndjbTlr ZFcgTjBjeX dnWVc1ayBJ RUZpWWxacF pTIHdnZDJo cFkyZ2cgWm 05amRYTmxj eSBCdmJpQn dhR0Z5IGJX RmpaWFYwYV cgTmhiSE11 UEdKeSBQam N1SUVGaVlt IDkwZENCTV lXSnYgY21G MGIzSnBaWC BNZ2FHRnpJ RzFoIFpHVW djMlYyWlgg SmhiQ0J1Yj NSaCBZbXhs SUdGamNYIF ZwYzJsMGFX OXUgY3lCdm RtVnlJSCBS b1pTQjVaV0 Z5IGN5d2dh VzVqYkggVm thVzVuSUhS byBaU0J3YU dGeWJXIEZq WlhWMGFXTm ggYkNCamIy MXdZVyA1NU lFRnNlbUVn IFEyOXljRz l5WVggUnBi MjRnYVc0Zy BNakF3TVNC aGJtIFFnZE dobElHNTEg ZEhKcGRHbH ZiaSBCamIy MXdZVzU1IE lFNWxjM1Jz WmUgS0FtWE 1nYVc1bSBZ VzUwSUc1MW RIIEpwZEds dmJpQmsgYV hacGMybHZi aSBCcGJpQX lNREUzIExq eGljajQ0TG kgQlVhR1Vn WTI5dCBjR0 Z1ZVNCb1lY IE1nWVNCem RISnYgYm1j Z1oyeHZZbS BGc0lIQnla WE5sIGJtTm xMQ0IzYVgg Um9JRzl3Wl hKaCBkR2x2 Ym5NZ2FXID RnYjNabGNp QXggTmpBZ1 kyOTFibiBS eWFXVnpJR0 Z1IFpDQndj bTlrZFcgTj BjeUJ6YjJ4 ayBJR2x1SU cxdmNtIFVn ZEdoaGJpQX ggTmpBdVBH SnlQaiBrdU lFbHVJREl3 IE1UWXNJRU ZpWW0gOTBk Q0JNWVdKdi BjbUYwYjNK cFpYIE1nYl dGa1pTQmgg SUcxaGFtOX lJRyBKeVpX RnJkR2h5IG IzVm5hQ0Jw YmkgQjBhR1 VnWm1sbCBi R1FnYjJZZ1 pHIGxoWjI1 dmMzUnAgWT NNZ2QybDBh QyBCMGFHVW daR1YyIFpX eHZjRzFsYm 4gUWdiMlln WVNCeSBZWE JwWkNCMFpY IE4wSUdadm NpQjAgYUdV Z1dtbHJZUy BCMmFYSjFj eTRnIFZHaH BjeUIwWlgg TjBJR052ZF d4ayBJSEJ5 YjNacFpHIF VnY21WemRX eDAgY3lCcG JpQnFkWCBO MElHWnBkbV VnIGRHOGdj MlYyWlcgNG daR0Y1Y3l3 ZyBZMjl0Y0 dGeVpXIFFn ZEc4Z2QyVm wgYTNNZ2Qy bDBhQyBCMG NtRmthWFJw IGIyNWhiQ0 IwWlggTjBh VzVuSUcxbC BkR2h2WkhN dVBHIEp5UG pFd0xpQkIg WW1KdmRIUW dURyBGaWIz SmhkRzl5IG FXVnpJR2x6 SUcgTnZiVz FwZEhSbCBa Q0IwYnlCem RYIE4wWVds dVlXSnAgYk dsMGVTQmhi bSBRZ2FHRn pJSE5sIGRD Qm5iMkZzY3 kgQjBieUJ5 WldSMSBZMl VnYVhSeklH IE5oY21Kdm JpQm0gYjI5 MGNISnBibi BRc0lHbHVZ M0psIFlYTm xJR1Z1Wlgg Sm5lU0JsWm 1acCBZMmxs Ym1ONUxDIE JoYm1RZ1pH VmogY21WaG MyVWdkMiBG MFpYSWdkWE 5oIFoyVXVJ RlJvWlMgQm piMjF3WVc1 NSBJR2hoY3 lCaGJIIE52 SUdsdGNHeG wgYldWdWRH VmtJSCBKbF kzbGpiR2x1 IFp5QndjbT luY20gRnRj eUJoYm1RZy BhWE1nWTI5 dWRHIGx1ZF c5MWMyeDUg SUhkdmNtdH BibSBjZ2RH OGdjbVZrIG RXTmxJSGRo YzMgUmxJR2 x1SUdsMCBj eUJ2Y0dWeV lYIFJwYjI1 ekxnPT0KIC AgICAgICA8 L3NwYW4+Ci AgICAgICAg CiAgICAgIC Ag